$1.19
-0.25[-17.36%]
At close: Apr 23
$1.19
0[0.00%]
After Hours: 6:24PM EDT
Sunshine Biopharma
(NASDAQ:SBFM)Sunshine Biopharma Stock (NASDAQ:SBFM), Earnings Estimates, EPS, and Revenue
Sunshine Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.080
Quarterly Revenue Estimate
$7M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$24.1M
Analyze the earnings history of Sunshine Biopharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/08/2024 | PM | SBFM | Q1 | -$0.08 | -$0.08 | — | — | $4.89M | $7.00M | — | — | Get Alert |
| 03/28/2024 | AM | SBFM | Q4 | -$1.50 | -$0.03 | -$0.06 | -100.00% | $3.94M | $6.10M | $7.68M | 25.90% | Get Alert |
| 11/13/2023 | AM | SBFM | Q3 | -$0.08 | -$0.06 | -$0.04 | 33.33% | $132.81K | $6.00M | $5.60M | -6.70% | Get Alert |
| 08/10/2023 | PM | SBFM | Q2 | -$0.03 | — | -$0.02 | — | $150.31K | — | $5.56M | — | Get Alert |
| 05/10/2023 | PM | SBFM | Q1 | -$0.23 | — | -$0.08 | — | $122.64K | — | $4.89M | — | Get Alert |
| 04/04/2023 | AM | SBFM | Q4 | — | — | -$1.50 | — | — | — | $3.94M | — | Get Alert |
| 11/07/2022 | AM | SBFM | Q3 | -$1.59 | — | -$0.08 | — | $50.38K | — | $132.81K | — | Get Alert |
| 08/06/2022 | AM | SBFM | Q2 | -$1.21 | — | -$0.03 | — | $52.87K | — | $150.31K | — | Get Alert |
| 05/06/2022 | AM | SBFM | Q1 | -$2.82 | — | -$0.23 | — | $40.06K | — | $122.64K | — | Get Alert |
FAQ
When is Sunshine Biopharma (NASDAQ:SBFM) reporting earnings?
Sunshine Biopharma (SBFM) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
What were the latest earnings per share (EPS) for Sunshine Biopharma (NASDAQ:SBFM)?
The Actual EPS was $-0.06, which missed the estimate of $-0.03.
What were Sunshine Biopharma’s (NASDAQ:SBFM) revenues?
The Actual Revenue was $7.7M, which beat the estimate of $6.1M.
Browse earnings estimates, EPS, and revenue on all stocks.